✦ LIBER ✦

Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing

✍ Scribed by Hiroshi Suzuki; Shiro Iino; Kazuo Shiraki; Yoshihiro Akahane; Hiroaki Okamoto; Kenji Domoto; Shunji Mishiro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative safety and immunogenicity of

✍ Emil Miskovsky; Kenneth Gershman; Mary Lou Clements; Thomas Cupps; G. Calandra; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 544 KB

Safety and immunogenicity of a novel mam

✍ Raul Raz; Ron Dagan; Aharon Gallil; Gerta Brill; Imad Kassis; Ronit Koren 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Improved immunogenicity in mice of a mam

✍ D. Shouval; Y. Ilan; R. Adler; R. Deepen; A. Panet; Z. Even-Chen; M. Gorecki; W. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 957 KB

Immunogenicity and safety in newborns of

✍ J.C. Soulié; P. Devillier; J. Santarelli; A. Goudeau; P. Vermeulen; M. Guellier; 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Preparation and Immunogenicity of a Pich

✍ TAN, C; YUAN, J; JIN, O; JIANG, L; HU, B 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 148 KB

T-cell and antibody response characteris

✍ Christopher D Jones; Mark Page; Andrew Bacon; Edward Cahill; Matthew Bentley; St 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 427 KB